# | Title | Journal | Year | Citations |
---|
1 | Xenogeneic extracellular matrix as a scaffold for tissue reconstruction | Transplant Immunology | 2004 | 662 |
2 | Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man | Transplant Immunology | 1993 | 339 |
3 | High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells | Transplant Immunology | 2003 | 280 |
4 | Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical report | Transplant Immunology | 1998 | 252 |
5 | ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms | Transplant Immunology | 1999 | 234 |
6 | Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings | Transplant Immunology | 1997 | 214 |
7 | Advances in tissue engineering of blood vessels and other tissues | Transplant Immunology | 1997 | 190 |
8 | Pathways of allorecognition: implications for transplantation tolerance | Transplant Immunology | 2002 | 186 |
9 | Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate | Transplant Immunology | 2008 | 181 |
10 | Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation | Transplant Immunology | 2007 | 173 |
11 | Second Report (1998–2006) of the International Registry of Hand and Composite Tissue Transplantation | Transplant Immunology | 2007 | 160 |
12 | Natural killer cells and their receptors | Transplant Immunology | 2002 | 159 |
13 | HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms | Transplant Immunology | 2005 | 157 |
14 | Hepatic tissue engineering | Transplant Immunology | 2004 | 151 |
15 | A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions | Transplant Immunology | 1999 | 142 |
16 | Microarray analysis of MicroRNA expression in acute rejection after renal transplantation | Transplant Immunology | 2008 | 140 |
17 | Muscle-derived stem cells for musculoskeletal tissue regeneration and repair | Transplant Immunology | 2004 | 138 |
18 | The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation | Transplant Immunology | 1993 | 134 |
19 | Immunological aspects of blood transfusions | Transplant Immunology | 2002 | 124 |
20 | Heart valve tissue engineering | Transplant Immunology | 2004 | 121 |
21 | Xenotransplantation of solid organs in the pig-to-primate model | Transplant Immunology | 2009 | 121 |
22 | The role of natural anti-galα1–3gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants | Transplant Immunology | 1997 | 116 |
23 | Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys | Transplant Immunology | 2003 | 116 |
24 | Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury | Transplant Immunology | 2005 | 114 |
25 | Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells | Transplant Immunology | 1997 | 113 |
26 | IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo | Transplant Immunology | 2004 | 109 |
27 | Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32) | Transplant Immunology | 1998 | 108 |
28 | Tolerance induction in clinical transplantation | Transplant Immunology | 2004 | 105 |
29 | Tolerance versus immune response — MicroRNAs as important elements in the regulation of the HLA-G gene expression | Transplant Immunology | 2009 | 105 |
30 | The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice | Transplant Immunology | 2007 | 102 |
31 | Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection | Transplant Immunology | 2004 | 98 |
32 | Tryptophan catabolism generates autoimmune-preventive regulatory T cells | Transplant Immunology | 2006 | 97 |
33 | Clinical tolerance following liver transplantation: Long term results and future prospects | Transplant Immunology | 2007 | 96 |
34 | Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches | Transplant Immunology | 2005 | 95 |
35 | Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts | Transplant Immunology | 1995 | 94 |
36 | Clinical relevance of pretransplant anti-HLA donor-specific antibodies: Does C1q-fixation matter? | Transplant Immunology | 2013 | 94 |
37 | Generation and function of antigen-specific suppressor and regulatory T cells | Transplant Immunology | 2003 | 93 |
38 | Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation | Transplant Immunology | 2002 | 88 |
39 | CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response | Transplant Immunology | 2003 | 88 |
40 | The molecular genetics of blood group polymorphism | Transplant Immunology | 2005 | 87 |
41 | Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model | Transplant Immunology | 2011 | 86 |
42 | Immunology of pregnancy—pregnancy as a remission inducing agent in rheumatoid arthritis | Transplant Immunology | 2002 | 85 |
43 | Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD | Transplant Immunology | 2007 | 84 |
44 | Activation of Tim-3–Galectin-9 pathway improves survival of fully allogeneic skin grafts | Transplant Immunology | 2008 | 84 |
45 | Distribution of the major xenoantigen (gal(α1–3)gal) for pig to human xenografts | Transplant Immunology | 1994 | 83 |
46 | Natural anti-galactose α1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts | Transplant Immunology | 2002 | 83 |
47 | A novel strategy against ischemia and reperfusion injury: cytoprotection with heme oxygenase system | Transplant Immunology | 2002 | 83 |
48 | Rejection and recipient age | Transplant Immunology | 2002 | 83 |
49 | Cellular therapies for liver replacement | Transplant Immunology | 2004 | 83 |
50 | The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients | Transplant Immunology | 2015 | 82 |